Presentation
13 March 2024 δ-Aminolevulinic Acid (ALA) in fluorescence guided surgery
Author Affiliations +
Abstract
Aminolevulinic acid is a naturally occurring small protein that is widely utilized in most cells of the body as a building block for heme synthesis. While is has many uses in medicine, the most seminal change in its use came in the 1990s with the adoption of it as a topical agent that led to production of the photosensitizer protoporphyrin IX, within dermatology lesions such as actinic keratoses. The PpIX allows for effective photodynamic therapy treatment of many lesions, not just in the skin but in many squamous tissues, bacteria, and even some solid tumors. The administration routes approved for human use now include topical, intravesical, and oral, with it being used as a fluorescent guide to surgical resection. The use in bladder cancer resection has been adopted for decades, although its acceptance in the urology surgery community remains controversial. The use in glioma resection has been approved for nearly a decade and its adoption within the neurosurgery community is steadily growing. Recent data has shown that PpIX also has a delayed fluorescence which originates in the absence of oxygen to quench the triplet state, and so it provides a unique way to visualize hypoxia.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Brian W. Pogue "δ-Aminolevulinic Acid (ALA) in fluorescence guided surgery", Proc. SPIE PC12825, Molecular-Guided Surgery: Molecules, Devices, and Applications X, PC1282501 (13 March 2024); https://doi.org/10.1117/12.3012664
Advertisement
Advertisement
KEYWORDS
Medical imaging

Resection

Proteins

Quenching

Skin

Solids

Surgery

Back to Top